Market Cap

Beximco Pharmaceuticals Limited Market Capitalization:

£171.8 Million

GBP as of July 1, 2024

US$217.3 Million

business Beximco Pharmaceuticals Limited Company Profile

Beximco Pharmaceuticals Limited Main Stock Listing

LSE: BXP

Market Capitalization History of Beximco Pharmaceuticals Limited

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $80.13 B
MERCK Kommanditgesellschaft auf Aktien $71.24 B
Takeda Pharmaceutical Company Limited $41.23 B
Haleon plc $37.32 B
Teva Pharmaceutical Industries Limited $18.88 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Beximco Pharmaceuticals Limited market cap

Date Market Cap YoY Change
Jan. 1, 2024 £459.2 M -9.19%
Jan. 1, 2023 £505.7 M -50.61%
Jan. 1, 2022 £1.02 B 2.08%
Jan. 1, 2021 £1.00 B 148.47%
Jan. 1, 2020 £403.7 M -9.57%
Jan. 1, 2019 £446.5 M -22.31%
Jan. 1, 2018 £574.7 M -5.47%
Jan. 1, 2017 £607.9 M 168.80%
Jan. 1, 2016 £226.2 M 45.83%
Jan. 1, 2015 £155.1 M 33.57%
Jan. 1, 2014 £116.1 M -33.41%
Jan. 1, 2013 £174.4 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Beximco Pharmaceuticals Limited Categories

languages Healthcare languages Drug Manufacturers—Specialty & Generic

Stocks & Indices

Beximco Pharmaceuticals Limited has the following listings and related stock indices.


Stock: LSE: BXP

Stock: XSTU: R2WA

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.